| Term 
 
        | Name the principal regulators of plasma Ca2+ within the body- |  | Definition 
 
        | Parathyroid hormone (PTH) 1,25 Dihydroxyvitamin D (calcitriol)
 Calcitonin
 |  | 
        |  | 
        
        | Term 
 
        | What drugs should be considered when treating hypocalcemia? |  | Definition 
 
        | Calcium gluconate Calcium chloride
 Calcium carbonate (oral)
 Calcium lactate (oral)
 Calcitriol
 |  | 
        |  | 
        
        | Term 
 
        | Clinical presentation of HYPERcalcemia? |  | Definition 
 
        | Fatigue Mental confusion
 Nausea, vomiting
 Anorexia
 Polydipsia (excessive thirst)
 Polyuria (peeing often)
 Cardiac conduction abnormalities
 |  | 
        |  | 
        
        | Term 
 
        | Treatment of hypercalcemia (three steps)? |  | Definition 
 
        | 1. Volume expansion (rehydration) 2. Increase calcium excretion using loop diuretics (Furosemide acts on thick ascending loop of Henle to knock out the Na-K-Cl cotransporter, all of the electrolytes go out)
 3. Short term therapy with Calcitonin (in CHF or renal dysfuction patients)
 |  | 
        |  | 
        
        | Term 
 
        | Bisphosphonates you can use for treatment of hypercalcemia? |  | Definition 
 
        | Pamidronate Etidronate
 Zoledronate
 |  | 
        |  | 
        
        | Term 
 
        | What would severe hypercalcemia be best managed with? |  | Definition 
 
        | Loop diuretic (Furosemide) plus saline infusion |  | 
        |  | 
        
        | Term 
 
        | Clinical presentation of HYPOcalcemia? |  | Definition 
 
        | Muscle spasms (Chvostek's & Trousseau's sign) Seizure
 Respiratory arrest
 Laryngeal spasm
 Irritability
 |  | 
        |  | 
        
        | Term 
 
        | Calcium is given to somebody with hypocalcemia. What are the two forms of elemental calcium? Two forms of oral calcium? |  | Definition 
 
        | Elemental 1. Calcium gluconate
 2. Calcium chloride (Tums)
 Oral
 1. Calcium carbonate
 2. Calcium lactate
 |  | 
        |  | 
        
        | Term 
 
        | What is given to a patient suffering from hypocalcemia that has renal dysfunction? |  | Definition 
 
        | Calcitriol (a Vitamin D metabolite) |  | 
        |  | 
        
        | Term 
 
        | What are the bisphosphonates to know? What do they all end in? |  | Definition 
 
        | -nate Etidronate
 Alendronate
 Ibandronate
 Pamidronate
 Tiludronate
 Risedronate
 |  | 
        |  | 
        
        | Term 
 
        | What bisphosphate is first line therapy for treatment of osteoporosis and Paget's disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What bisphosphate is used for prophylaxis of osteoporosis and is the DOC for prophylaxis of glucocorticoid-induced osteoporosis? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibit osteoclastic activity - more specifically, the reduce both the resorption and formation of hydroxyapatite crystals. |  | 
        |  | 
        
        | Term 
 
        | How are bisphosphonates administered? |  | Definition 
 
        | IV only (lousy bioavailability if given orally) |  | 
        |  | 
        
        | Term 
 
        | Clinical indications for bisphosphonates? |  | Definition 
 
        | First-line therapy for osteoporosis Osteoporosis prevention
 Osteolysis associated with tumor
 Hypercalcemia (prevent unlocking of calcium from bone)
 |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of bisphosphonates? |  | Definition 
 
        | Esophageal and gastric irritation, GI bleeding Diarrhea, nausea
 |  | 
        |  | 
        
        | Term 
 
        | When are bisphosphonates CI? |  | Definition 
 
        | CI in compromised renal function, peptic ulcer disease |  | 
        |  | 
        
        | Term 
 
        | What drug is a calcimimetic? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | When is Cinacalcet indicated? |  | Definition 
 
        | Used for treatment of hypercalcemic states or when there are excessive calcium levels resulting from parathyroid carcinoma |  | 
        |  | 
        
        | Term 
 
        | What characteristic of Cinacalcet makes it likely to have a high risk of interactions with other drugs? |  | Definition 
 
        | It is highly bound to plasma proteins (high risk of interaction with NSAIDS, Verapamil, Digoxin) |  | 
        |  | 
        
        | Term 
 
        | What two kinds of calcitonin may be taken? How are they administered? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is calcitonin indicated for? |  | Definition 
 
        | Paget's disease Adjunctive treatment of hypercalcemic emergencies (when a pt presents with hypercalcemia, a ventricular arrhythmia may be present)
 |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of calcitonin? |  | Definition 
 
        | Headache Weakness
 Nausea, vomiting (likely with initial dose, then will subside)
 |  | 
        |  | 
        
        | Term 
 
        | Other than calcitonin, what else is used to counteract the actions of parathyroid hormone? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is Plicamycin and what does it do? |  | Definition 
 
        | A cytotoxic antibiotic that also lowers serum calcium concentration. It inhibits hypercalcemic action of Vitamin D AND inhibits the effects of PTH on osteoclasts.
 |  | 
        |  | 
        
        | Term 
 
        | What are the indications for use of Plicamycin? |  | Definition 
 
        | Because of its high toxicity and low therapeutic index, it is used only is hospital settings. It is used for treatment of hypercalcemia resulting from advanced neoplasms. |  | 
        |  | 
        
        | Term 
 
        | What are the CIs for Plicamycin? |  | Definition 
 
        | Myelosuppression Pregnancy
 Bleeding disorders
 Hepatic & renal dysfunction
 |  | 
        |  | 
        
        | Term 
 
        | What are the three Vitamin D preparations? |  | Definition 
 
        | 1,25 Dihydroxyvitamin D3 (Calcitriol) Vitamin D2 (Ergocalciferol)
 Doxercalciferol
 |  | 
        |  | 
        
        | Term 
 
        | What is Calcitriol indicated for? |  | Definition 
 
        | Hypocalcemic patients Patients with hypoparathyroidism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CI in hypercalcemia and in patients on cardiac glycosides |  | 
        |  | 
        
        | Term 
 
        | What is Ergocalciferol indicated for? |  | Definition 
 
        | Hypophophatemia Osteomalacia
 Osteoporosis
 Prophylaxis and treatment of rickets
 |  | 
        |  | 
        
        | Term 
 
        | What is Doxercalciferol indicated for? |  | Definition 
 
        | Hyperparathyroidism (reduction of PTH) |  | 
        |  | 
        
        | Term 
 
        | When should Doxercalciferol not be used? |  | Definition 
 
        | Cautious use in renal of hepatic dysfunction and in pregnancy |  | 
        |  | 
        
        | Term 
 
        | What is the recombinant drug used in treatment calcium homeostasis? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | A recombinant form of PTH. It stimulates osteoblastic activity (new bone formation). Only agent that does this! (IMPORTANT! Possible STEP 1 question!)
 |  | 
        |  | 
        
        | Term 
 
        | How is Teriparatide adminstered? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | When is Teriparatide indicated? |  | Definition 
 
        | Indicated in osteoporosis in women and men who fail conventional therapy |  | 
        |  | 
        
        | Term 
 
        | How long can Teriparatide be used? |  | Definition 
 
        | 21 months, beyond that is causes osteosarcoma |  | 
        |  | 
        
        | Term 
 
        | What drug is a selective estrogen receptor modulator? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | It is an agonist to bone (prevents osteoporosis) and antagonist to breast tissue (reduces incidence of estrogen-dependent breast cancers) |  | 
        |  |